Yum Chaehyun, Andolino Chaylen, Layosa Marjorie Anne, Coleman Michael, Hursting Stephen D, Teegarden Dorothy
Department of Nutrition Science, Interdepartmental Nutrition Program, Purdue University, West Lafayette, IN, 47907, USA.
Purdue University Institute for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA.
Diabetol Metab Syndr. 2024 Nov 28;16(1):288. doi: 10.1186/s13098-024-01535-1.
Leptin, an energy balance regulator secreted by adipocytes, increases metastatic potential of breast cancer cells. The impact on cancer cell metabolism remains unclear given that most studies of leptin and breast cancer cell metabolism utilize supraphysiological glucose concentrations.
Using two murine models of metastatic triple-negative breast cancer (TNBC) differing in genetic alterations (4T1: p53 and Pik3ca mutations; metM-Wnt: increased Wnt signaling) and cultured in physiological (5 mM) glucose media, we tested the hypothesis that leptin increases migration of metastatic breast cancer cells through regulation of glucose metabolism.
Our results showed that leptin treatment, compared with vehicle, increased cell migration in each cell line, with decreased leptin receptor (Ob-R) mRNA expression in 4T1, but not metM-Wnt, cells. AMP-activated protein kinase (AMPK) was activated in 4T1 with leptin treatment but decreased in metM-Wnt. Leptin decreased fatty acid synthase (Fasn) and carnitine palmitoyltransferase 1a (Cpt1a) mRNA expression in 4T1 cells but increased their expression in metM-Wnt cells. Fatty acid oxidation was not necessary for leptin-induced migration in either cell line. Leptin increased palmitate synthesis from glucose in metM-Wnt, but not 4T1 cells. Moreover, although leptin increased glucose transporter 1 (Glut1) mRNA expression in both cell lines and inhibition of glycolysis blocked leptin-induced migration in metM-Wnt, but not 4T1 cells.
Taken together, these results demonstrate that at physiological glucose concentrations, leptin increases migration of 4T1 and metM-Wnt cells via shared and distinct effects on energy metabolism, suggesting that the type of TNBC genetic alteration plays a role in differential metabolic regulation of leptin-induced migration.
瘦素是一种由脂肪细胞分泌的能量平衡调节因子,可增加乳腺癌细胞的转移潜能。鉴于大多数关于瘦素与乳腺癌细胞代谢的研究使用的是超生理浓度的葡萄糖,其对癌细胞代谢的影响仍不清楚。
我们使用两种在基因改变方面存在差异的转移性三阴性乳腺癌(TNBC)小鼠模型(4T1:p53和Pik3ca突变;metM-Wnt:Wnt信号增强),并在生理浓度(5 mM)的葡萄糖培养基中培养,以验证瘦素通过调节葡萄糖代谢增加转移性乳腺癌细胞迁移的假说。
我们的结果表明,与对照组相比,瘦素处理可增加每个细胞系中的细胞迁移,4T1细胞中瘦素受体(Ob-R)mRNA表达降低,但metM-Wnt细胞中未降低。瘦素处理使4T1细胞中的AMP激活蛋白激酶(AMPK)活化,但在metM-Wnt细胞中降低。瘦素降低了4T1细胞中脂肪酸合酶(Fasn)和肉碱棕榈酰转移酶1a(Cpt1a)的mRNA表达,但在metM-Wnt细胞中增加了它们的表达。脂肪酸氧化对于任一细胞系中瘦素诱导的迁移并非必需。瘦素增加了metM-Wnt细胞而非4T1细胞中葡萄糖生成棕榈酸酯的过程。此外,尽管瘦素增加了两个细胞系中葡萄糖转运蛋白1(Glut1)的mRNA表达,并且糖酵解抑制可阻断metM-Wnt细胞而非4T1细胞中瘦素诱导的迁移。
综上所述,这些结果表明,在生理葡萄糖浓度下,瘦素通过对能量代谢的共同和不同影响增加4T1和metM-Wnt细胞的迁移,提示TNBC基因改变类型在瘦素诱导迁移的差异代谢调节中起作用。